Skip to main content
Clinical Trials/EUCTR2017-004187-35-SE
EUCTR2017-004187-35-SE
Active, not recruiting
Phase 1

The FACE (Facial nerve palsy And Cortisone Evaluation) study in children: a randomised double-blind, placebo-controlled, multicenter trial.

Falun Hospital0 sites500 target enrollmentOctober 31, 2018

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Not specified
Sponsor
Falun Hospital
Enrollment
500
Status
Active, not recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 31, 2018
End Date
TBD
Last Updated
last year
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
Falun Hospital

Eligibility Criteria

Inclusion Criteria

  • 1\.1\-17 years of age
  • 2\.Acute peripheral facial nerve palsy
  • 3\.Less than 72 hours of duration of symptoms
  • 4\.Signed informed consent.
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range: 500
  • F.1\.2 Adults (18\-64 years) no
  • F.1\.2\.1 Number of subjects for this age range 0
  • F.1\.3 Elderly (\>\=65 years) no
  • F.1\.3\.1 Number of subjects for this age range 0

Exclusion Criteria

  • 2\.Central facial nerve palsy
  • 3\.Malformations in head and neck
  • 4\.Conditions not compatible with cortisone treatment (hypertension, diabetes mellitus type 1, psychiatric disorder, active or latent tuberculosis, intolerance of lactose)
  • 5\.Current or past oncological diagnosis
  • 6\.Other serious medical conditions (meningitis, encephalitis, stroke)
  • 7\.Acute otitis media
  • 8\.Signs of herpes simplex or varicella zoster infection (vesicles in the ear region)
  • 9\.Pregnancy or breastfeeding
  • 10\.Use of any systemic or inhaled steroids within 2 weeks prior onset of symptoms
  • 11\.Immunization with live vaccine 1 month prior onset of symptoms

Outcomes

Primary Outcomes

Not specified

Similar Trials